OUR PORTFOLIO
We are partnering with companies and entrepreneurs that are advancing frontiers in science and technology.
Epsilogen
Boston, MA
​
Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer.
​
Acesion Pharma
Copenhagen, Denmark
​
Acesion Pharma is developing a next generation antiarrhythmic drug that targets the SK channel to treat atrial fibrillation (A-fib) without causing significant extracardiac and cardiac related adverse events.
​
Odyssey Therapeutics
Boston, MA
​
Odyssey is creating next generation precision medicines for patients with cancer and inflammatory diseases by targeting key signaling nodes that are critical drivers of disease.
​
VITTORIA Biotherapeutics
Philadelphia, PA
Harnessing the unrealized potential of CD5 as a novel checkpoint for cell therapies.
​
SHIRATRONICS
Minneapolis, MN
​Transform the lives of those living with Chronic Migraine.​
​
Nuvig Therapeutics
Menlo Park, CA
​
Developing a first-in-class Fc fragment
immunomodulator to treat autoimmune diseases.​
​